Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors (Q77501492)
Jump to navigation
Jump to search
scientific article published on 01 March 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors |
scientific article published on 01 March 2000 |
Statements
Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors (English)
Centers for Disease Control and Prevention (CDC)
1 reference